[Stage T1 malignant tumors of the arythenoid. Analysis of a series of 26 cases].
26 malignant tumours of the arytenoid classified as T1 according to the UICC 1987, were treated in the ENT and Cervico-Facial Surgery wards to Hospital Laennec between 1961 and 1990. The natural history of these lesions, locoregional efficiency of the different treatments used, the part played by chemotherapy, survival, causes of death and therapeutic modalities used as a last measure, have been analysed. The frequency of tumours with neuroendocrine has been emphasized. Such a diagnosis should be questioned when the initial biopsy does not diagnose a well differentiated epidermoid carcinoma. The use of argyrophil colouring in order to find neurosecretive granules helps in carrying out the diagnosis. The treatment of tumours, classed T1 N0 M0, of the arytenoid, is based on partial, laryngeal surgery associated with a preventive, jugulo-carotidian-ipsilateral ganglionary intervention.
Laccourreye
O
O
Service d'Otorhinolaryngologie et de Chirurgie Cervico-Faciale, Hôpital Laënnec, Paris.
Brasnu
D
D
Chabardes
E
E
Fichaux
P
P
Menard
M
M
Carnot
F
F
Laccourreye
H
H
D000206:Actuarial Analysis; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002276:Carcinoid Tumor / Q000473:pathology* / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000473:pathology* / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007817:Laryngeal Cartilages / Q000473:pathology* / Q000601:surgery; D007822:Laryngeal Neoplasms / Q000473:pathology* / Q000628:therapy; D007825:Laryngectomy / Q000379:methods; D008197:Lymph Node Excision; D008297:Male; D008875:Middle Aged; D009333:Neck; D009367:Neoplasm Staging
Tumeurs malignes de l'aryténoïde classées T1. Analyse d'une série de 26 cas.